German hope for endometrial and ovarian cancer sufferers
This article was originally published in Clinica
Executive Summary
Too many German women die unnecessarily because ovarian and womb cancer are diagnosed too late to offer them any chance of effective treatment, claims German Cancer Aid. In an effort to address the situation, the society is sponsoring an initiative by Peter Altevogt from the Cancer Research Centre in Heidelberg (KFZH) and Mina Fogel from the Kaplan Hospital in Rehovot, Israel, to the tune of E194,000 ($196,000). The institutions have developed a new diagnostic method for cancer detection by identifying a protein that they believe could serve as a tumour marker.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.